Skip Navigation

VAERS Bibliography - June 2004

  1. Immunization Registry Progress--United States, January-December 2002. MMWR Morb.Mortal.Wkly.Rep. 53 (20): 431-433; May 28, 2004.

  2. Outbreak of Varicella Among Vaccinated Children--Michigan, 2003. MMWR Morb.Mortal.Wkly.Rep. 53 (18): 389-392; May 14, 2004.

  3. Aronson, N. E.; Santosham, M.; Comstock, G. W.; Howard, R. S.; Moulton, L. H.; Rhoades, E. R.; Harrison, L. H. Long-Term Efficacy of BCG Vaccine in American Indians and Alaska Natives: A 60-Year Follow-Up Study. JAMA. 291 (17): 2086-2091; May 5, 2004.

  4. Assendelf, W. J.; Scholten, R. J.; Offringa, M. Pneumococcal Vaccination for the Elderly in The Netherlands? Assessment of the Quality and Content of Available Comparative Studies. Neth.J.Med. 62 (2): 36-44; February, 2004.

  5. Beran, J.; Douda, P.; Gniel, D.; Zent, O. Long-Term Immunity After Vaccination Against Tick-Borne Encephalitis With Encepur Using the Rapid Vaccination Schedule. Int.J.Med.Microbiol.  293 Suppl 37:130-3; April, 2004.

  6. Beske, F. [Active Vaccination Current Status and Required Action]. Gesundheitswesen. 66 (5): 352-354; May, 2004.

  7. 7. Beyer, W. E.; Palache, A. M.; Luchters, G.; Nauta, J.; Osterhaus, A. D. Seroprotection Rate, Mean Fold Increase, Seroconversion Rate: Which Parameter Adequately Expresses Seroresponse to Influenza Vaccination? Virus Res. 103 (1-2): 125-132; July, 2004.

  8. Brimnes, N. Variolation, Vaccination and Popular Resistance in Early Colonial South India. Med.Hist. 48 (2): 199-228; April, 2004.

  9. Cassimatis, D. C.; Atwood, J. E.; Engler, R. M.; Linz, P. E.; Grabenstein, J. D.; Vernalis, M. N. Smallpox Vaccination and Myopericarditis: a Clinical Review. J.Am.Coll.Cardiol. 43 (9): 1503-1510; May 5, 2004.

  10. Chabot, I.; Goetghebeur, M. M.; Gregoire, J. P. The Societal Value of Universal Childhood Vaccination. Vaccine. 22 (15-16): 1992-2005; May 7, 2004.

  11. Davis, M. M. Race-Based Immunization Recommendations and the Potential to Reduce Health Disparities. JAMA. 291 (18): 2253-2255; May 12, 2004.

  12. De Bruijn, I. A.; Nauta, J.; Gerez, L.; Palache, A. M. Virosomal Influenza Vaccine: a Safe and Effective Influenza Vaccine With High Efficacy in Elderly and Subjects With Low Pre-Vaccination Antibody Titers.  Virus Res. 103 (1-2): 139-145; July, 2004.

  13. Dye, C. A Booster for Tuberculosis Vaccines. JAMA. 291 (17): 2127-2128; May 5, 2004.

  14. Escribano, Montaner A.; De, Juanes Pardo, Jr. Infection by Influenza Virus in Childhood: a Call for Broader Influenza Vaccination.  Arch.Bronconeumol. 40 (5): 231-235; May, 2004.

  15. Flannery, B.; Schrag, S.; Bennett, N. M.; Lynfield, R.; Harrison, L. H.; Reingold, A.; Cieslak, P. R.; Hadler, J.; Farley, M. M.; Facklam, R. R.; Zell, E. R.; Whitney, C. G. Impact of Childhood Vaccination on Racial Disparities in Invasive Streptococcus Pneumoniae Infections. JAMA. 291 (18): 2197-2203; May 12, 2004.

  16. Geier, M. R.; Geier, D. A. Gastrointestinal Adverse Reactions Following Anthrax Vaccination: an Analysis of the Vaccine Adverse Events Reporting System (VAERS) Database.  Hepatogastroenterology. 51 (57): 762-767; May, 2004.

  17. Glass, R. I.; Bresee, J. S.; Parashar, U. D.; Jiang, B.; Gentsch, J. The Future of Rotavirus Vaccines: a Major Setback Leads to New Opportunities. Lancet. 363 (9420): 1547-1550; May 8, 2004.

  18. Hannoun, C.; Megas, F.; Piercy, J. Immunogenicity and Protective Efficacy of Influenza Vaccination. Virus Res. 103 (1-2): 133-138; July, 2004.

  19. Harper, S. A.; Fukuda, K.; Uyeki, T. M.; Cox, N. J.; Bridges, C. B. Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm.Rep. 53 (RR-6): 1-40; May 28, 2004.

  20. Hepburn, M. J.; Dooley, D. P.; Murray, C. K.; Hospenthal, D. R.; Hill, B. L.; Nauschuetz, W. N.; Davis, K. A.; Crouch, H. K.; McAllister, C. K. Frequency of Vaccinia Virus Isolation on Semipermeable Versus Nonocclusive Dressings Covering Smallpox Vaccination Sites in Hospital Personnel. Am.J.Infect.Control. 32 (3): 126-130; May, 2004.

  21. Hethcote, H. W.; Horby, P.; McIntyre, P. Using Computer Simulations to Compare Pertussis Vaccination Strategies in Australia. Vaccine. 22 (17-18): 2181-2191; June 2, 2004.

  22. Johansen, H.; Nguyen, K.; Mao, L.; Marcoux, R.; Gao, R. N.; Nair, C. Influenza Vaccination. Health Rep. 15 (2): 33-43; March, 2004.

  23. Johansson, E. L.; Bergquist, C.; Edebo, A.; Johansson, C.; Svennerholm, A. M. Comparison of Different Routes of Vaccination for Eliciting Antibody Responses in the Human Stomach. Vaccine. 22 (8): 984-990; February 25, 2004.

  24. Kelly, H.; Attia, J.; Andrews, R.; Heller, R. F. The Number Needed to Vaccinate (NNV) and Population Extensions of the NNV: Comparison of Influenza and Pneumococcal Vaccine Programmes for People Aged 65 Years and Over. Vaccine. 22 (17-18): 2192-2198; June 2, 2004.

  25. Kitchener, S. Viscerotropic and Neurotropic Disease Following Vaccination With the 17D Yellow Fever Vaccine, ARILVAX((R)). Vaccine. 22 (17-18): 2103-2105; June 2, 2004.

  26. Lesser, D. Risk of Contact Vaccinia From Immunization Sites. JAMA. 291 (19): 2313-2314; May, 2004.

  27. Maier, G. Smallpox: What Every Nurse Should Know. Ohio.Nurses Rev. 78 (3): 4-6; March, 2003.

  28. Martin, J. Travel Vaccination: an Update.  Nurs.Stand. 18 (34): 47-53; May 5, 2004.

  29. Meeker, J. Meningococcal Disease--Prevention and Intervention. Ohio.Nurses Rev. 77 (6): 15-18; July, 2002.

  30. Mercado, U.; Acosta, H.; Avendano, L. Influenza Vaccination of Patients With Systemic Lupus Erythematosus.  Rev.Invest Clin. 56 (1): 16-20; January, 2004.

  31. Minor, P. D. Polio Eradication, Cessation of Vaccination and Re-Emergence of Disease. Nat.Rev.Microbiol. 2 (6): 473-482; June, 2004.

  32. Nichol, K. L.; Mendelman, P. Influence of Clinical Case Definitions With Differing Levels of Sensitivity and Specificity on Estimates of the Relative and Absolute Health Benefits of Influenza Vaccination Among Healthy Working Adults and Implications for Economic Analyses. Virus Res. 103 (1-2): 3-8; July, 2004.

  33. Nishiura, H.; Tang, I. M. Modeling for a Smallpox-Vaccination Policy Against Possible Bioterrorism in Japan: the Impact of Long-Lasting Vaccinal Immunity.  J.Epidemiol. 14 (2): 41-50; March, 2004.

  34. Okada, K.; Ueda, K.; Morokuma, K.; Kino, Y.; Tokugawa, K.; Nishima, S. Seroepidemiologic Study on Pertussis, Diphtheria, and Tetanus in the Fukuoka Area of Southern Japan: Seroprevalence Among Persons 0-80 Years Old and Vaccination Program.  Jpn.J.Infect.Dis. 57 (2): 67-71; April, 2004.

  35. Ovsyannikova, I. G.; Jacobson, R. M.; Vierkant, R. A.; Shane, Pankratz, V; Jacobsen, S. J.; Poland, G. A. Associations Between Human Leukocyte Antigen (HLA) Alleles and Very High Levels of Measles Antibody Following Vaccination. Vaccine. 22 (15-16): 1914-1920; May 7, 2004.

  36. Qureshi, A. M.; Hughes, N. J.; Murphy, E.; Primrose, W. R. Factors Influencing Uptake of Influenza Vaccination Among Hospital-Based Health Care Workers. Occup.Med.(Lond). 54 (3): 197-201; May, 2004.

  37. Raman, S.; Siddiq, T. O.; Joseph, A.; Jones, A. H.; Haray, P. N.; Masoud, A. G. Vaccination Metastasis Following Percutaneous Endoscopic Gastrostomy. Hosp.Med. 65 (4): 246-247; April, 2004.

  38. Rentier, B.; Gershon, A. A. Consensus: Varicella Vaccination of Healthy Children--a Challenge for Europe. Pediatr.Infect.Dis.J. 23 (5): 379-389; May, 2004.

  39. Rottem, M.; Shoenfeld, Y. Vaccination and Allergy. Curr.Opin.Otolaryngol.Head Neck Surg. 12 (3): 223-231; June, 2004.

  40. Schneider, J. Protection Against Infectious Diseases by DNA-Based Vaccination Strategies--Lessons for Allergy Treatment? Arb.Paul Ehrlich Inst.Bundesamt Sera Impfstoffe Frankf A M. (94): 300-303; 2003.

  41. Soriano Faura, F. J.; Bras, Marquillas J.; Delgado Dominguez, J. J.; Galbe Sanchez-Ventura, J.; Merino, Moina M.; Sanchez-Ruiz Cabello, F. J.; Pallas Alonso, C. R.; Colomer, Revuelta J. [Prevention in Childhood and Adolescence]. Aten.Primaria. 32 Suppl 2:143-58; December, 2003.

  42. Steyer, T. E.; Ragucci, K. R.; Pearson, W. S.; Mainous, A. G., III  The Role of Pharmacists in the Delivery of Influenza Vaccinations. Vaccine. 22 (8): 1001-1006; February 25, 2004.

  43. Subias Loren, P. J.; Perula, de Torres; Moreno, Martin J.; Martin-Rabadan, Muro M.; Llergo, Munoz A.; Iglesias, Rodal M.; Garcia, Mata, Jr.; Bauza, Nicolay K. [Population Survey to Determine Perceptions on Preventive Activities].  Aten.Primaria. 32 Suppl 2:5-14; December, 2003.

  44. Temime, L.; Guillemot, D.; Boelle, P. Y. Short- and Long-Term Effects of Pneumococcal Conjugate Vaccination of Children on Penicillin Resistance. Antimicrob.Agents Chemother. 48 (6): 2206-2213; June, 2004.

  45. van den Bosch, W. J. Pneumococcal Vaccination for Healthy Elderly: a Comment.  Neth.J.Med. 62 (2): 66-68; February, 2004.

  46. Vogtlander, N. P.; Brown, A.; Valentijn, R. M.; Rimmelzwaan, G. F.; Osterhaus, A. D. Impaired Response Rates, but Satisfying Protection Rates to Influenza Vaccination in Dialysis Patients. Vaccine. 22 (17-18): 2199-2201; June 2, 2004.

  47. Wiertsema, S. P.; Sanders, E. A.; Veenhoven, R. H.; Heerbeek, N. V.; Hof, S. V.; Berbers, G. A.; Rijkers, G. T. Antibody Levels After Regular Childhood Vaccinations in the Immunological Screening of Children With Recurrent Otitis Media. J.Clin.Immunol. 24(4): 354-360; July, 2004.

  48. Yavuz, T.; Arbak, P.; Ozturk, C. E.; Kocabay, K. [BCG Vaccination: Where Are We Now?]. Tuberk.Toraks. 52 (1): 47-51; 2004.

  49. Zarocostas, J. UNICEF Taps Religious Leaders in Vaccination Push. Lancet. 363 (9422): 1709; May 22, 2004.